BECTON, DICKINSON AND COMPANY Funds and ETFs Becton, Dickinson and Company
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 234.7 USD | -2.36% |
|
+1.35% | -3.75% |
| May. 03 | TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271 | MT |
| May. 02 | Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280 | MT |
ETFs positioned on Becton, Dickinson and Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 15.40% | 215 M€ | +10.80% | - | |
| 2.47% | 6 M€ | +16.84% | - | |
| 2.09% | 18 M€ | +3.01% | - | |
| 1.71% | 4,592 M€ | +11.18% | ||
| 0.87% | 9 M€ | -.--% | - | |
| 0.83% | 2 M€ | +6.77% | ||
| 0.81% | 469 M€ | -2.05% | - | |
| 0.81% | 3,859 M€ | +18.82% | - | |
| 0.79% | 2 M€ | +20.44% | - | |
| 0.69% | 5 M€ | -72.95% | - | |
| 0.60% | 5 M€ | -.--% | - | |
| 0.43% | 1,448 M€ | -.--% | - | |
| 0.43% | 219 M€ | +17.17% | - | |
| 0.43% | 717 M€ | +6.41% | ||
| 0.38% | 8 M€ | -.--% | ||
| 0.33% | 26 M€ | +2.55% | - | |
| 0.32% | 10 M€ | +6.51% | ||
| 0.30% | 276 M€ | +11.40% | - | |
| 0.29% | 1,848 M€ | +18.39% | - | |
| 0.29% | 559 M€ | +14.30% | - | |
| 0.27% | 9 M€ | +4.05% | - | |
| 0.27% | 736 M€ | +6.44% | ||
| 0.27% | 414 M€ | +9.64% | - | |
| 0.27% | 1,006 M€ | -.--% | - | |
| 0.26% | 27 M€ | +15.49% | - |
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
234.7
USD
Average target price
278.3
USD
Spread / Average Target
+18.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.75% | 67.82B | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B | |
| -0.03% | 25.03B |
- Stock Market
- Equities
- BDX Stock
- Funds and ETFs Becton, Dickinson and Company
